From “Hunger Hormone” to “It’s Complicated”: Ghrelin Beyond Feeding Control

Physiology ◽  
2022 ◽  
Vol 37 (1) ◽  
pp. 5-15
Author(s):  
Sara L. Deschaine ◽  
Lorenzo Leggio

Discovered as a peptide involved in releasing growth hormone, ghrelin was initially characterized as the “hunger hormone.” However, emerging research indicates that ghrelin appears to play an important part in relaying information regarding nutrient availability and value and adjusting physiological and motivational processes accordingly. These functions make ghrelin an interesting therapeutic candidate for metabolic and neuropsychiatric diseases involving disrupted nutrition that can further potentiate the rewarding effect of maladaptive behaviors.

Author(s):  
Q.J. Luo ◽  
J.C. MacRae

Circulating concentrations of insulin-like growth factor-1 (IGF-1) are closely related to the nutrition of animals and their rates of growth. The major site of IGF-1 production is thought to be the liver. Whilst growth hormone (GH) is thought to be the main regulator of IGF-1 production in farm animals, in laboratory rats, altering the GH status of the animal (without hyperphysectomy) has little influence on circulating IGF-1 levels. A series of studies have been conducted with primary cultured rat and sheep hepatocytes to investigate the influence of GH and nutrient availability on the production of IGF-1 by liver cells.


Author(s):  
Eva Horvath ◽  
Kalman Kovacs ◽  
B. W. Scheithauer ◽  
R. V. Lloyd ◽  
H. S. Smyth

The association of a pituitary adenoma with nervous tissue consisting of neuron-like cells and neuropil is a rare abnormality. In the majority of cases, the pituitary tumor is a chromophobic adenoma, accompanied by acromegaly. Histology reveals widely variable proportions of endocrine and nervous tissue in alternating or intermingled patterns. The lesion is perceived as a composite one consisting of two histogenetically distinct parts. It has been suggested that the neuronal component, morphologically similar to secretory neurons of the hypothalamus, may initiate adenoma formation by releasing stimulatory substances. Immunoreactivity for growth hormone releasing hormone (GRH) in the neuronal component of some cases supported this view, whereas other findings such as consistent lack of growth hormone (GH) cell hyperplasia in the lesions called for alternative explanation.Fifteen tumors consisting of a pituitary adenoma and a neuronal component have been collected over a 20 yr. period. Acromegaly was present in 11 patients, was equivocal in one, and absent in 3.


2005 ◽  
Vol 39 (10) ◽  
pp. 10
Author(s):  
BETSY BATES
Keyword(s):  

2009 ◽  
Vol 40 (8) ◽  
pp. 38
Author(s):  
SHERRY BOSCHERT
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document